top of page
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute

Journal of Health and Medical Sciences

ISSN 2622-7258

Screen Shot 2018-08-12 at 1.24.09 AM.png
Screen Shot 2018-08-12 at 1.24.02 AM.png
Screen Shot 2018-08-12 at 1.23.57 AM.png
Screen Shot 2018-08-12 at 1.23.52 AM.png
open access

Published: 20 December 2023

An Experimental Evidence for Antibacterial Activity of Propolis on Bacteria from Lebanese Patients

Amena Allouch, Zainab Dagher, Dr. Ali Khalil Mezher

Safir High School, Taakhi medical centre

journal of social and political sciences
pdf download

Download Full-Text Pdf



Pages: 199-209

Keywords: Propolis, Anti-Bacterial, Anti-Fungal, Lebanon


Propolis, with its distinctive chemical composition, has been known for therapeutic potential in treating numerous diseases. This study investigated whether propolis has an antibacterial effect on bacteria in Lebanon. Twenty- eight samples of gram-negative and gram-positive bacteria were collected from Raii Hospital and Al-Taakhi Medical Center in Gazieh, South Lebanon. Each sample was streaked on three different Petri dishes with different percentages of propolis under aseptic conditions. The results were recorded visually and confirmed by Gram staining after incubation for 24 h at 37°C. The obtained results show that propolis inhibited the growth of 18% of the total number of collected bacteria. The majority of bacteria on which propolis had an inhibitory effect were gram- positive bacteria, which inhibited 50% of them, whereas it only inhibited the growth of 9% of the gram-negative bacteria. Propolis was also shown to have an antifungal effect.


  1. Ahangari Z., Naseri M., Vatandoost F. (2018). Propolis: Chemical Composition and Its Applications in Endodontics. . Iran. Endod. J., 13:285–292.

  2. Ahmed R., Tanvir E., Hossen M.S., Afroz R., Ahmmed I., Rumpa N.-E., Paul S., Gan S.H., Sulaiman S.A., Khalil M.I. (2017). Antioxidant properties and cardioprotective mechanism of Malaysian propolis in rats. Evidence-Based Complement. Alternat. Med.

  3. Al-Hariri M.T. (2011). Propolis and its direct and indirect hypoglycemic effect. J. Family Commun. Med. , 18:152.

  4. Alhassan Sa-eed, Eric S Donkor, Reuben E Arhin, Patience B Tetteh-Quarcoo, Simon K Attah, Daniel E K Kabotso, Fleischer C N Kotey, Nicholas T K D Dayie. (2023). In vitro antimicrobial activity of crude propolis extracts and fractions. FEMS Microbes, 4

  5. Almuhayawi, M.S. (2020). Propolis as a novel antibacterial agent. Saudi J. Biol. Sci. 27, 3079–3086

  6. Aminimoghadamfarouj N. & Nematollahi A. (2017). Propolis diterpenes as a remarkable bio-source for drug discovery development: a review. Int. J. Mol. Sci., 18:1290.

  7. Ansorge S., Reinhold D., Lendeckel U. (2003). Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-Beta1 production of human immune cells. Naturforsch., 58:580–589.

  8. Araujo M.A., Libério S.A., Guerra R.N., Ribeiro M.N.S., Nascimento F.R. (2012). mechanisms of action underlying the anti-inflammatory and immunomodulatory effects of propolis: A brief review. Rev. Bras. Farmacogn. , 22:208–219.

  9. Balouiri, M., Sadiki, M., & Ibnsouda, S. K. (2016). Methods for in vitro evaluating antimicrobial activity: A review. Journal of pharmaceutical analysis, 6(2), 71–79.

  10. Bouchelaghem S. (2022). Propolis characterization and antimicrobial activities against Staphylococcus aureus and Candida albicans: A review. Saudi Journal of Biological Sciences., 29(4):1936–1946.

  11. Bratko, Filipic & Gradisnik, Lidija & Gregorič, Dunja & Pereyra, Adriana & Ružić-Sabljić, Eva & Mazija, Hrvoje. (2020). The polyphenol content and antimicrobial activity of selected propolis' extracts. Journal of Agriculture Science & Technology. 10. 350-364.

  12. Burdock GA. (1998). Review of the biological properties and toxicity of bee propolis (propolis). Food and Chemical Toxicology., 36(4):347–363.

  13. Chamoun, K., Farah, M., Araj, G., Daoud, Z., Moghnieh, R., Salameh, P., Saade, D., Mokhbat, J., Abboud, E., Hamze, M., Abboud, E., Jisr, T., Haddad, A., Feghali, R., Azar, N., El-Zaatari, M., Chedid, M., Haddad, C., Zouain Dib Nehme, M., Barakat, A., … (2016). Lebanese Society of Infectious Diseases Study Group (L)SID study group). Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, 46, 64–70.

  14. Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. (2012). The Impact of the Gut Microbiota on Human Health: An Integrative View. . Cell. , 148:1258–1270. https://

  15. Cornara L., Biagi M., Xiao J., Burlando B.;. (2017). Therapeutic properties of bioactive compounds from different honeybee products. Front. Pharmacol., ;8:412.

  16. D'Auria, F. D., Tecca, M., Scazzocchio, F., Renzini, V., & Strippoli, V. (2003). Effect of propolis on virulence factors of Candida albicans. Journal of chemotherapy (Florence, Italy), 15(5), 454–460.

  17. De Castro SL. (2001). Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product. Annual Review of Biomedical Sciences. , 3:49–83.

  18. Gómez-Caravaca A.M., Gómez-Romero M., Arráez-Román D., Segura-Carretero A., Fernández-Gutiérrez A. (2006). Advances in the analysis of phenolic compounds in products derived from bees. J. Pharmac. Biomed. Anal. , 41:1220–1234.

  19. Gucwa, K., Kusznierewicz, B., Milewski, S., Van Dijck, P., & Szweda, P. (2018). Antifungal Activity and Synergism with Azoles of Polish Propolis. Pathogens (Basel, Switzerland), 7(2), 56.

  20. Hamzé, M., Osman, M., Mallat, H., & Raad, E.B. (2017). Prevalence and antibiotic susceptibility patterns of bacteria causing urinary tract infections in Youssef Hospital Center: first report from Akkar governorate, North of Lebanon. The International Arabic Journal of Antimicrobial Agents, 7.

  21. Hausen BM, Wollenweber E, Senff H, Post B. Propolis allergy. (1987). The sensitizing properties of 1,1-dimethylallyl caffeic acid ester. Contact Dermatitis , 17(3):171–177.

  22. Kim Y. H. & C. H. J. (2011). The effects of Korean propolis against foodborne pathogens and transmission electron microscopic examination. New biotechnology, 28(6):713–718.

  23. Khodor, M., Hamzé, M., Mallat, H., Chahine, Z., Chalouhi, G., Achkar, M., & Azar, N. (2022). Co-infection in patients with COVID-19 in Tripoli Northern Lebanon: germs involved and antibiotic sensitivity profile. The International Arabic Journal of Antimicrobial Agents.

  24. Kujumgiev A, Tsvetkova I, Serkedjieva Y, Bankova V, Christov R, Popov S. (1999). Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. . Journal of Ethnopharmacology, 64(3):235–240.

  25. Kumar N, Ahmad MKK, Dang R, Husain A. . (2008). Antioxidant and antimicrobial activity of propolis from Tamil Nadu zone. . Journal of Medicinal Plants Research. , 2(12):361–364. .

  26. Manso, T., Lores, M., & de Miguel, T. (2021). Antimicrobial Activity of Polyphenols and Natural Polyphenolic Extracts on Clinical Isolates. Antibiotics (Basel, Switzerland), 11(1), 46.

  27. Marcucci M. (1995). Propolis: chemical composition, biological properties and therapeutic activity. Apidologie. , 26(2):83–99.

  28. Mutlu Sariguzel, F.; Berk, E.; Koc, A.N.; Sav, H.; Demir, G. (2016) Antifungal activity of Propolis against yeasts isolated from blood culture: In vitro evaluation. J. Clin. Lab. Anal., 30, 513–516.).

  29. Özcan M. (1999). Antifungal properties of propolis. Grasas Aceites., 50:395–398.

  30. Ożarowski, M., Karpiński, T. M., Alam, R., & Łochyńska, M. (2022). Antifungal Properties of Chemically Defined Propolis from Various Geographical Regions. Microorganisms, 10(2),364.

  31. Pimenta, H. C., Violante, I. M., Musis, C. R., Borges, Á. H., & Aranha, A. M. (2015). In vitro effectiveness of Brazilian brown propolis against Enterococcus faecalis. Brazilian oral research, 29,

  32. Przybyłek, I., & Karpiński, T. M. (2019). Antibacterial Properties of Propolis. Molecules (Basel, Switzerland), 24(11), 2047.

  33. Ristivojević P, Dimkić I, Guzelmeric E, Trifković J, Knežević M, Berić T, Yesilada E, Milojković-Opsenica D, Stanković S. (2018). Profiling of Turkish propolis subtypes: Comparative evaluation of their phytochemical compositions, antioxidant and antimicrobial activities. LWT, 95:367–379.

  34. Sikkema J., de Bont J. A., Poolman B. (1995). Mechanisms of membrane toxicity of hydrocarbons. Microbiol. Rev. 59, 201–222.

  35. Silva-Carvalho, R.; Baltazar, F.; Almeida-Aguiar, C. (2015). Propolis: A complex natural product with a plethora of biological activities that can be explored for drug

  36. development. Evid. Based Complement. Altern. Med.

  37. Touzani, S., Imtara, H., Katekhaye, S., Mechchate, H., Ouassou, H., Alqahtani, A. S., Noman, O. M., Nasr, F. A., Fearnley, H., Fearnley, J., Paradkar, A., ElArabi, I., & Lyoussi, B. (2021). Determination of Phenolic Compounds in Various Propolis Samples Collected from an African and an Asian Region and Their Impact on Antioxidant and Antibacterial Activities. Molecules (Basel, Switzerland), 26(15), 4589.

  38. Uzel, A.; Önçağ, Ö.; Çoğulu, D.; Gençay, Ö. (2005). Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol. Res. 2005, 160, 189–195.

  39. Wagh V. D. (2013). Propolis: a wonder bees product and its pharmacological potentials. Advances in pharmacological sciences, 308249.

  40. Zhang X., Wang G., Gurley E.C., & Zhou H. (2014). Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS ONE. , 9:e107072.

bottom of page